Working… Menu

A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04046549
Recruitment Status : Recruiting
First Posted : August 6, 2019
Last Update Posted : November 26, 2021
Information provided by (Responsible Party):
Viela Bio

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 17, 2022
Estimated Study Completion Date : February 24, 2023